Israel - anglès - Ministry of Health

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 12.5 mg; metformin hydrochloride 500 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.

Israel - anglès - Ministry of Health

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 5 mg; metformin hydrochloride 500 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.

Israel - anglès - Ministry of Health

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 5 mg; metformin hydrochloride 500 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.

Regne Unit - anglès - VMD (Veterinary Medicines Directorate)

zoetis uk limited - toceranib - film-coated tablet - anti neoplastic agent - dogs

Regne Unit - anglès - VMD (Veterinary Medicines Directorate)

zoetis uk limited - toceranib - film-coated tablet - anti neoplastic agent - dogs

Regne Unit - anglès - VMD (Veterinary Medicines Directorate)

zoetis uk limited - toceranib - film-coated tablet - anti neoplastic agent - dogs

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - calcium pantothenate, quantity: 6.52 mg (equivalent: pantothenic acid, qty 6 mg); ascorbic acid, quantity: 60 mg; sage oil spanish, quantity: 25 microlitre; zinc citrate trihydrate, quantity: 14.73 mg (equivalent: zinc, qty 4.6 mg); riboflavin, quantity: 1.6 mg; folic acid, quantity: 200 microgram; nicotinamide, quantity: 18 mg; ferrous fumarate, quantity: 36.5 mg (equivalent: iron, qty 12 mg); pyridoxine hydrochloride, quantity: 2.43 mg (equivalent: pyridoxine, qty 2 mg); biotin, quantity: 150 microgram; thiamine nitrate, quantity: 1.73 mg (equivalent: thiamine, qty 1.4 mg); cyanocobalamin, quantity: 2.5 microgram; magnesium oxide, quantity: 223.83 mg (equivalent: magnesium, qty 135 mg) - tablet, film coated - excipient ingredients: pregelatinised starch; purified water; microcrystalline cellulose; magnesium stearate; maltodextrin; acacia; hypromellose; calcium carbonate; medium chain triglycerides; isomalt; copper chlorophyllin - enhance/promote energy levels ; maintain/support energy levels ; enhance/promote/physical endurance/capacity/stamina ; maintain/support physical endurance/capacity/stamina ; helps enhance/promote body energy reserves ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support (state vitamin/mineral) within normal range ; maintain/support mental concentration/focus/clarity ; enhance/improve/promote/increase cognitive performance ; enhance/improve/promote/increase mental endurance/stamina ; enhance/improve/promote/increase mental alertness/wakefulness ; enhance/improve/promote/increase memory/recall ; maintain/support memory/mental recall ; enhance/improve/promote/increase short term memory

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - ethinylestradiol; levonorgestrel - oral tablet - 30microgram ; 150microgram

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - ethinylestradiol; levonorgestrel - oral tablet - 30microgram ; 150microgram

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

bayer new zealand limited - ethinylestradiol 0.03mg; levonorgestrel 0.15mg - tablet - active: ethinylestradiol 0.03mg levonorgestrel 0.15mg excipient: calcium carbonate glycerol glycol montanate iron oxide yellow lactose monohydrate macrogol 6000 magnesium stearate maize starch povidone   purified talc   sucrose titanium dioxide - oral contraception